Free Guide
GLP-1 Compounding Guide
Millions of people turned to compounding pharmacies when GLP-1 medications were in short supply. Here's everything you need to know about how compounding works, the difference from brand-name drugs, and how to evaluate your options safely.
Educational content only.The regulatory landscape for compounded GLP-1 medications is changing rapidly. Always consult your prescribing physician and verify your pharmacy's current legal status. This page was last reviewed in mid-2025 — check the FDA drug shortage database for the most current status.
What Is Pharmaceutical Compounding?
The Basics
Compounding is the process of creating a customized medication for an individual patient. A licensed compounding pharmacy takes an active pharmaceutical ingredient (API) and formulates it into a specific dose, delivery method, or combination not commercially available. Compounded GLP-1 medications use the same active ingredient as brand-name drugs — semaglutide or tirzepatide — but are mixed by the pharmacy rather than manufactured by the drug company.
Why Compounding Became Popular for GLP-1s
Compounded GLP-1 medications exploded in popularity starting in 2022–2023 when FDA drug shortages made Ozempic, Wegovy, Mounjaro, and Zepbound nearly impossible to obtain. During an FDA-declared shortage, federal law permits licensed compounding pharmacies to compound copies of the drug for patient-specific prescriptions. Cost is the other major driver — brand-name GLP-1s can cost $800–$1,300/month without insurance, while compounded versions typically run $150–$400/month.
Two Types of Compounding Pharmacies
Not all compounding pharmacies are created equal. The regulatory framework and quality standards differ significantly between 503A and 503B facilities.
503A Traditional Compounding Pharmacy
Compounded for a specific patient with a valid prescription. Must be made in a state-licensed pharmacy. Subject to state board of pharmacy oversight, not direct FDA manufacturing regulations.
Pros
- Lower minimum orders
- More personalized dosing
- Widely available via telehealth platforms
Cons
- Not subject to FDA Current Good Manufacturing Practices (CGMP)
- Quality standards vary by pharmacy
- Limited batch testing requirements
503B Outsourcing Facility
Federally registered facilities that can compound in larger batches for hospitals and providers without patient-specific prescriptions. Subject to FDA inspections and CGMP standards — much closer to pharmaceutical manufacturing quality.
Pros
- FDA inspected and registered
- Adherence to CGMP quality standards
- Batch testing for potency and sterility
- Higher consistency between doses
Cons
- Generally more expensive than 503A
- Fewer options available to individual patients
- Not all telehealth providers use 503B
FDA Regulatory Timeline
The legal status of compounded GLP-1 medications has changed significantly. Here's the key timeline.
2022–2023
FDA declares semaglutide (Ozempic/Wegovy) drug shortage — compounding permitted by law during shortage periods.
Mar 2024
FDA removes lower-dose semaglutide formulations from shortage list. Some compounders must stop or reformulate. 2.4mg Wegovy dose remained on shortage list longer.
Oct 2024
FDA declares tirzepatide (Mounjaro/Zepbound) shortage resolved. Enforcement discretion period begins for compounders to wind down.
Early 2025
FDA issues warning letters to 503A and 503B pharmacies selling compounded semaglutide and tirzepatide outside shortage protections. Enforcement ramps up.
Ongoing
Legal battles between compounding pharmacies and FDA continue. Regulatory landscape remains in flux — check FDA drug shortage database and your pharmacy's compliance status.
Safety Considerations
Compounded medications can be safe when sourced and used correctly. Know what to look for.
API Source and Purity
medium concernCompounded GLP-1s use semaglutide or tirzepatide API sourced from third-party suppliers, often from overseas. Reputable pharmacies test incoming API for identity and purity. Ask your pharmacy for API certificates of analysis.
Salt Form Differences
high concernBrand-name Ozempic and Wegovy use the sodium salt form of semaglutide. Some compounded versions use semaglutide acetate, which has a different molecular weight. FDA has noted this as a concern — confirm your pharmacy uses the correct form.
Sterility and Contamination
high concernCompounded injectables must be prepared under sterile conditions. 503B facilities have rigorous sterility testing. 503A pharmacies vary widely. Check whether your pharmacy performs sterility and endotoxin testing on finished product.
Dosing Accuracy
medium concernSelf-administered injections from vials (vs. auto-injector pens) introduce variability. Concentration, volume, and reconstitution (for lyophilized products) all affect actual dose delivered. Use insulin syringes and carefully follow instructions.
Added Ingredients
low concernSome compounders add vitamin B12, L-carnitine, or NAD+ to their formulations — marketing this as 'enhanced.' FDA has questioned the clinical rationale and safety of these add-ins. Simpler is generally safer.
Cost Comparison
Approximate monthly costs without insurance (mid-2025). Prices vary by dose, pharmacy, and region.
| Product | Est. Monthly Cost | Insurance Coverage |
|---|---|---|
| Ozempic (semaglutide, Novo Nordisk) | $800–$1,000 | Often for T2D, rarely for weight loss |
| Wegovy (semaglutide, Novo Nordisk) | $1,100–$1,350 | Some commercial plans, limited Medicare |
| Mounjaro (tirzepatide, Eli Lilly) | $950–$1,100 | Often for T2D, rarely for weight loss |
| Zepbound (tirzepatide, Eli Lilly) | $550–$650 (direct Lilly) | Growing commercial plan coverage |
| Compounded Semaglutide (503A) | $150–$350 | Almost never covered by insurance |
| Compounded Tirzepatide (503A) | $200–$450 | Almost never covered by insurance |
*Eli Lilly's direct-to-patient Zepbound program offers significantly lower prices than retail pharmacy.
Questions to Ask Your Compounding Pharmacy
A reputable pharmacy will have clear answers to all of these. Evasiveness is a red flag.
Is this pharmacy a 503A or 503B facility?
Where is the API sourced from and can I see certificates of analysis?
Is the semaglutide in sodium or acetate salt form?
Is the finished product tested for sterility, potency, and endotoxins?
Is the pharmacy licensed in my state?
What is the concentration (mg/mL) and how do I calculate my dose?
Are there any added ingredients beyond the active API?
What is the cold chain storage and shipping process?
What happens to my prescription now that the FDA shortage has ended?
If the FDA Shortage Has Ended…
Once FDA removes a drug from the shortage list, the legal authority for compounding that drug changes significantly. 503A and 503B compounders may be prohibited from continuing to produce it. If you're on compounded GLP-1s, ask your provider about transition options to brand-name or the Lilly direct program.
Compounding Is Not “Fake”
Compounding has been part of pharmacy practice for over 100 years. Hospitals use compounded medications daily. The concern with GLP-1 compounding isn't the concept of compounding itself — it's the variability in quality between pharmacies and the regulatory uncertainty now that shortages are resolved.
Maximize Whatever Form You're Taking
Whether you're on compounded or brand-name GLP-1 medication, the fundamentals are the same: high-protein diet, resistance training, and consistent tracking. GLPMAXX helps you do all three.